Back to Trades
Mayes Patrick A
EVP & Chief Scientific OfficerCIK 0002079962
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 13
- Companies
- 1
- Active
- 2025–2026
Mayes Patrick A, EVP & Chief Scientific Officer, has filed 8 SEC reports (2025–2026), all concentrated in INCYTE CORP (INCY), totaling $17.5M in disclosed volume. Weighing $0 bought versus $6.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Aug 7 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | $273.6K |
| Aug 4 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | $5.7M |
| Jul 20 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Grant | $3.0M |
| Jul 16 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Tax withheld | $224.2K |
| Jul 7 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Tax withheld | $40.9K |
| Jan 21 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Award | $448.0K |
| Oct 3 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Tax withheld | $136.0K |
| Aug 5 | INCY INCYTE CORP | Mayes Patrick A | EVP & Chief Scientific Officer | Other | $0 |
8 filings